Hologic, Inc [HOLX] stock prices are up 0.81% to $65.01 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HOLX shares have gain 2.80% over the last week, with a monthly amount drifted -8.05%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hologic, Inc [NASDAQ: HOLX] stock has seen the most recent analyst activity on February 06, 2025, when Leerink Partners downgraded its rating to a Market Perform and also revised its price target to $75 from $80. Previously, Needham downgraded its rating to Hold on February 03, 2025. On December 13, 2024, Wolfe Research initiated with a Peer Perform rating. Needham reiterated its Buy rating but stick to its price target of $90 on December 10, 2024. Jefferies initiated its recommendation with a Hold and recommended $85 as its price target on December 10, 2024. Citigroup downgraded its rating to Neutral for this stock on October 01, 2024, and downed its price target to $85. In a note dated June 27, 2024, Stephens initiated an Overweight rating and provided a target price of $87 on this stock.
The stock price of Hologic, Inc [HOLX] has been fluctuating between $62.69 and $84.67 over the past year. Currently, Wall Street analysts expect the stock to reach $86 within the next 12 months. Hologic, Inc [NASDAQ: HOLX] shares were valued at $65.01 at the most recent close of the market. An investor can expect a potential return of 32.29% based on the average HOLX price forecast.
Analyzing the HOLX fundamentals
The Hologic, Inc [NASDAQ:HOLX] reported sales of 4.04B for trailing twelve months, representing a surge of 0.86%. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.18%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.15 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.31 points at the first support level, and at 63.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 65.68, and for the 2nd resistance point, it is at 66.35.
Ratios To Look Out For
It’s worth pointing out that Hologic, Inc [NASDAQ:HOLX]’s Current Ratio is 3.49. As well, the Quick Ratio is 2.78, while the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 3.61, the price to book ratio is 3.07 and price to earnings (TTM) ratio is 20.57.
Transactions by insiders
Recent insider trading involved Mitchell Essex D, Chief Operating Officer, that happened on Dec 04 ’24 when 24856.0 shares were sold. Officer, Mitchell Essex D completed a deal on Dec 04 ’24 to buy 24856.0 shares. Meanwhile, Chief Financial Officer Oberton Karleen Marie sold 52679.0 shares on Aug 29 ’24.
